Anaemia and its treatment in neurologically critically ill patients: being reasonable is easy without prospective trials by Naidech, Andrew M
Introduction
Th  e previous issue of Critical Care contains a report 
associating more severe anaemia with worse outcome 
after intracerebral haemorrhage. [1] Th   ese data are analo-
gous to published reports in subarachnoid hemorrhage 
and traumatic brain injury that link more severe anaemia 
with worse outcomes.
Anaemia and transfusion in critical illness
Th  e traditional goal for packed red blood cell (PRBC) 
transfusion was traditionally 10 g/dL, and revised down 
to <7 g/dL [2]with the exception of acute coronary syn-
dromes or acute resuscitation. Unfortunately, there have 
been no large, prospective trials of PRBC transfusion in 
patients speciﬁ  cally with neurologic disease.
Anaemia in the neurologically critically ill
Anaemia is associated with worse outcomes in non-
traumatic subarachnoid hemorrhage (ruptured brain 
aneurysm) [3]. Preventing brain hypoxia might be 
impor  tant to reduce the incidence and severity of 
cerebral infarction from vasospasm, and PRBC 
transfusion in that setting leads to improved markers of 
brain tissue function on positron emission tomography 
[4]. In patients with traumatic brain injury, brain oxygen 
monitors may show low brain oxygen tension that 
responds to PRBC trans  fusion [5]; the BOOST2 study is 
planned to assess if brain oxygen tension-guided therapy 
improves outcomes. A sub-study of the Transfusion 
Requirements in the Critical Care trial found no 
apparent eﬀ  ect of goal haemoglobin concentration on 
functional outcomes after neurotrauma [6].
Why would anaemia after intracerebral haemorrhage 
matter? Intracerebral haemorrhage does not lead to vaso-
spasm, but cerebral infarction can be found on magnetic 
resonance imaging scans [7] and this may impact out-
comes. Th   ere is probably not hypoxia around the clot [8], 
but there may be altered metabolism for a period of 
several days [9].
Remarkably few patients received a PRBC transfusion 
in the cohort, usually for surgery. Th   e nadir haemoglobin 
for patients with poor outcome (11.5 g/dL) was above the 
usual trigger for transfusion, so these data are of limited 
usefulness in determining when a PRBC transfusion 
should be given.
What one should think of anaemia in the neurologically 
critically ill is likely to depend on one’s preconceived 
notions. If you are convinced that anaemia in the Neuro-
ICU is linked to worse neuronal function, cerebral 
ischemia and poor outcome, you will probably 
(successfully) justify keeping your trigger for PRBC 
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observational data simply show sicker patients have 
worse outcomes despite the statistical correction for 
older age and larger haemorrhage size, then you will 
probably (successfully) justify keeping your trigger for 
PRBC transfusion at <7 g/dL. If you have a speciﬁ  c 
physiologic trigger (reduced brain oxygen tension, 
increased oxygen extraction fraction on positron 
emission tomography, and so on), few will argue with 
you. As Benjamin Franklin said, ‘So convenient a thing it 
is to be a reasonable creature, since it enables one to ﬁ  nd 
or make a reason for everything one has a mind to do.’
Conclusion
Anaemia is generally associated with worse outcomes in 
neurologically critically ill patients. Whether the out-
come can be improved by more frequent use of PRBC 
transfusion remains unclear.
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